Start with the National Cancer Institute’s (NCI) patient-facing cancer-prevention and infection-specific pages for evidence-reviewed background. Then check the CDC or your country’s public-health agency for current recommendations, and ask a clinician how they apply to your age, health, and history. This matters because an infection’s link to cancer is not the same as a universal recommendation to test, vaccinate, or treat.
Where should you look first?
NCI’s patient-facing Cancer Prevention Overview is a useful starting point. NCI says its PDQ database contains summaries of current published cancer information and that the summaries are based on an independent review of medical literature. Patient versions use nontechnical language; professional versions are more technical. PDQ summaries are not policy statements of NCI or NIH.
As an Amazon Associate I earn from qualifying purchases.
For a particular infection, use NCI’s Risk Factors: Infectious Agents page to find the relevant topic, then follow its links to public-health guidance. For current vaccination schedules or other recommendations, check the CDC in the United States or the relevant national public-health agency elsewhere. A clinician can help apply those recommendations to individual circumstances.
Quick wins for a faster PC:
Repair Windows errors before they cause bigger problemsFix Now →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Clear out junk files and repair common Windows errorsFree Scan →How can you tell whether a health page is trustworthy?
Before acting on a claim, check who published it, when it was reviewed, whom it applies to, and whether it distinguishes evidence from policy. An evidence-reviewed explanation can describe a risk without recommending that every reader be tested or treated.
#1 Best Overall
- Identify the publisher and review date. Prefer a named public-health agency or medical institution with a clear editorial process. Look for the page’s displayed revision or review date; a date in a search result may not reflect the current page.
- Check the audience and geography. A recommendation may depend on country, age, immune status, exposure, or medical history. Confirm that the guidance is for your location and situation.
- Separate association, cause, and risk. Find out whether the source says an infection causes or contributes to a cancer, is associated with it, or is a risk factor through another mechanism. These statements do not mean every infected person will develop cancer.
- Follow the citations. Check whether the page links to the underlying evidence or to the public-health authority responsible for the recommendation. Note whether a study involved a particular population or setting.
- Keep interventions distinct. Vaccination prevents some infections; testing identifies infection; treatment addresses infection; cancer screening looks for cancer or precancer in eligible groups. One does not automatically replace another.
Which infections are linked to cancer?
NCI describes several infection-related cancer risks, with different cancers and mechanisms. Its pages are a starting point for understanding those links, not a personal risk assessment.
| Infection | Cancers or risk described by NCI | What to know when reading about prevention |
|---|---|---|
| High-risk HPV | Cervical, anal, oropharyngeal, penile, vaginal, and vulvar cancers. | Persistent infection with high-risk types can cause cancer. HPV vaccination prevents new infections with targeted types; it does not treat an infection already present. |
| Hepatitis B (HBV) and hepatitis C (HCV) | Chronic infection with either virus can cause liver cancer. | HBV has a vaccine. HCV has no vaccine, but effective treatment can cure infection. Do not confuse vaccination guidance with testing and treatment guidance. |
| Helicobacter pylori (H. pylori) | Gastric adenocarcinoma and gastric MALT lymphoma. | Testing and eradication are appropriate in certain clinical circumstances; NCI says the evidence does not support widespread testing and eradication. |
| Epstein-Barr virus (EBV) | Selected lymphomas and cancers of the nose and throat. | EBV infection is common and lifelong, but most people do not develop symptoms. NCI says there is no vaccine to prevent EBV infection and no specific treatment for it. |
| HIV | NCI describes HIV as an indirect risk factor: immune suppression and co-infections help explain increased risk of some cancers. | HIV does not itself directly cause cancer, according to NCI. Risk-reduction care for people living with HIV can include antiretroviral therapy and management of other relevant risks. |
NCI estimates that infectious agents cause about 13% of cancers globally. This is a global estimate, not a current proportion for any particular country. See the NCI health-professional Cancer Prevention Overview for that estimate and its cited reference.
Rank #2
What prevention actions have evidence behind them?
Prevention depends on the infection. The relevant NCI pages explain what is established; local public-health guidance and clinical advice are needed for decisions about eligibility, testing, or care.
HPV: vaccination prevents targeted new infections
NCI estimates that HPV vaccination can prevent up to 90% of cancers caused by HPV infection and genital warts. “Up to” matters: this is an estimate, not a guarantee for an individual. The vaccine does not treat existing HPV infection or disease. NCI summarizes U.S. recommendations as routine vaccination at ages 11–12, with the series able to start at age 9 and catch-up vaccination through age 26; it describes two doses when vaccination starts before age 15 and three when it starts at age 15 or later. Check current CDC guidance because recommendations can change and circumstances such as immunocompromise may affect them. NCI’s background is in HPV and Cancer.
HBV and HCV: vaccination is not the same as viral testing or treatment
HBV vaccination can prevent infection. People who may be at risk should discuss testing with a clinician. HCV has no vaccine, but NCI says effective therapies can cure it. For details on infection-related cancer risks, consult NCI’s Risk Factors: Infectious Agents; use local public-health guidance for current testing and vaccination recommendations.
H. pylori: treatment is for appropriate clinical circumstances, not everyone
NCI reports that H. pylori eradication reduced gastric cancer incidence in studied groups, but also says available evidence does not support widespread testing and eradication. Its examples of people for whom testing and treatment are recommended include those with an active or documented ulcer history and people after certain gastric cancer or MALT lymphoma treatment. Unnecessary antibiotic treatment can contribute to antibiotic resistance, so do not self-test or self-treat; discuss symptoms or relevant history with a healthcare professional.
One result illustrates why context matters: a randomized trial in Shandong, China, found that two weeks of eradication treatment reduced gastric cancer incidence by nearly 50% over 22 years of follow-up. That finding comes from a high-incidence setting and does not establish that widespread testing and treatment is appropriate elsewhere. NCI explains the evidence and its limits in Helicobacter pylori (H. pylori) and Cancer.
EBV: distinguish cancer links from practical prevention options
NCI associates EBV with selected cancers but says there is no vaccine to prevent EBV infection and no specific treatment for it. Because infection is common and lifelong, avoid claims that ordinary exposure can be practically eliminated. See NCI’s Risk Factors: Infectious Agents for its infection-specific discussion.
Best Value
- New York Times Bestseller “This book may help those who are susceptible to illnesses that can be prevented.” ―His Holiness the Dalai Lama “Absolutely the best book I’ve read on nutrition and diet” –Dan Buettner, author of The Blue Zones Solution
HIV: look for integrated risk-reduction care
NCI describes antiretroviral therapy, hepatitis testing and treatment, relevant cancer screening, smoking cessation, and HPV vaccination as measures that can reduce cancer risk for people living with HIV. Screening recommendations for this group are specialized; use current clinical guidance and a clinician rather than applying general-population advice without checking. NCI explains the risk pathway in HIV Infection and Cancer Risk.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.How should you use a study result or a prevention recommendation?
Look for the difference between what a study observed and what a health authority recommends. A trial in one population can show that an intervention helped in that setting without establishing a universal screening or treatment policy. Likewise, an infection’s contribution to cancer risk does not establish that an individual will develop cancer.
For example, many HPV infections are controlled by the immune system, and most people infected with EBV do not develop symptoms. These facts do not erase the documented cancer links; they show why risk information should not be read as a prediction for every person. For each claim, check the population studied, the outcome measured, and whether the source separately states a recommendation for people like you.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Quick Recap
Which source should answer which question?
| Your question | Best next source | Why |
|---|---|---|
| What infections are linked to cancer, and what does the evidence say? | NCI patient PDQ and infection-specific pages. | They provide evidence-reviewed background in patient-facing language, while noting that PDQ is not policy. |
| What are the current vaccine, testing, or public-health recommendations where I live? | CDC in the United States, or your national or local public-health agency. | Recommendations can vary by place and change over time. |
| Does a recommendation apply to my health history or risk? | A healthcare professional familiar with your circumstances. | Individual factors can affect vaccination, testing, screening, and treatment decisions. |
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
